Adenosine hypothesis of schizophrenia--opportunities for pharmacotherapy.

MLA

Boison, Detlev, et al. “Adenosine Hypothesis of Schizophrenia--Opportunities for Pharmacotherapy.” Neuropharmacology, vol. 62, no. 3, Mar. 2012, pp. 1527–43. EBSCOhost, https://doi.org/10.1016/j.neuropharm.2011.01.048.

APA

Boison, D., Singer, P., Shen, H.-Y., Feldon, J., & Yee, B. K. (2012). Adenosine hypothesis of schizophrenia--opportunities for pharmacotherapy. Neuropharmacology, 62(3), 1527–1543. https://doi.org/10.1016/j.neuropharm.2011.01.048

Chicago

Boison, Detlev, Philipp Singer, Hai-Ying Shen, Joram Feldon, and Benjamin K Yee. 2012. “Adenosine Hypothesis of Schizophrenia--Opportunities for Pharmacotherapy.” Neuropharmacology 62 (3): 1527–43. doi:10.1016/j.neuropharm.2011.01.048.